For: | Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. World J Gastroenterol 2016; 22(8): 2601-2610 [PMID: 26937148 DOI: 10.3748/wjg.v22.i8.2601] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i8/2601.htm |
Number | Citing Articles |
1 |
Nicolás Goldaracena, Andre Gorgen, Gonzalo Sapisochin. Current status of liver transplantation for cholangiocarcinoma. Liver Transplantation 2018; 24(2): 294 doi: 10.1002/lt.24955
|
2 |
Karolina Maria Wronka, Michał Grąt, Jan Stypułkowski, Emil Bik, Waldemar Patkowski, Marek Krawczyk, Krzysztof Zieniewicz. Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma. Journal of Clinical Medicine 2019; 8(4): 458 doi: 10.3390/jcm8040458
|
3 |
Qun Zhou, Guoqiang Dong, Qiongjie Zhu, Yudong Qiu, Liang Mao, Jun Chen, Kefeng Zhou, Anning Hu, Jian He. Modification and comparison of CT criteria in the preoperative assessment of hepatic arterial invasion by hilar cholangiocarcinoma. Abdominal Radiology 2021; 46(5): 1922 doi: 10.1007/s00261-020-02849-0
|
4 |
Poowanai Sarkhampee, Weeris Ouransatien, Satsawat Chansitthichok, Nithi Lertsawatvicha, Paiwan Wattanarath. The impact of post-hepatectomy liver failure on long-term survival after liver resection for perihilar cholangiocarcinoma. HPB 2024; 26(6): 808 doi: 10.1016/j.hpb.2024.02.016
|
5 |
Xiaopeng Yao, Xinqiao Huang, Chunmei Yang, Anbin Hu, Guangjin Zhou, Mei Ju, Jianbo Lei, Jian Shu. A Novel Approach to Assessing Differentiation Degree and Lymph Node Metastasis of Extrahepatic Cholangiocarcinoma: Prediction Using a Radiomics-Based Particle Swarm Optimization and Support Vector Machine Model. JMIR Medical Informatics 2020; 8(10): e23578 doi: 10.2196/23578
|
6 |
Rishaan Pawaskar, Kevin Zhang Huang, Helen Pham, Adnan Nagrial, Mark Wong, Siobhan O’Neill, Henry Pleass, Lawrence Yuen, Vincent W. T. Lam, Arthur Richardson, Tony Pang, Christopher B. Nahm. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers 2024; 16(4): 698 doi: 10.3390/cancers16040698
|
7 |
Jun-Ke Wang, Hai-Jie Hu, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Fei Liu, Nan-Sheng Cheng, Fu-Yu Li. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?. Oncotarget 2017; 8(28): 45335 doi: 10.18632/oncotarget.17336
|
8 |
Felix Dondorf, Oliver Rohland, Aladdin Ali Deeb, Michael Ardelt, Utz Settmacher, Falk Rauchfuss. Value of palliative surgery in perihilar cholangiocarcinoma. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02854-z
|
9 |
Jizhe Li, Xianglong Tan, Xuan Zhang, Guodong Zhao, Minggen Hu, Zhiming Zhao, Rong Liu. Robotic radical surgery for hilar cholangiocarcinoma: A single‐centre case series. The International Journal of Medical Robotics and Computer Assisted Surgery 2020; 16(2) doi: 10.1002/rcs.2076
|
10 |
Wenbo Zou, Chunyu Zhu, Zizheng Wang, Xianglong Tan, Chenggang Li, Zhiming Zhao, Minggen Hu, Rong Liu. A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.649699
|
11 |
Naohisa Kuriyama, Haruna Komatsubara, Yuki Nakagawa, Koki Maeda, Toru Shinkai, Daisuke Noguchi, Takahiro Ito, Kazuyuki Gyoten, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Masashi Kishiwada, Hiroyuki Sakurai, Shugo Mizuno. Impact of Combined Vascular Resection and Reconstruction in Patients with Advanced Perihilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2021; 25(12): 3108 doi: 10.1007/s11605-021-05004-2
|
12 |
Christian Benzing, Felix Krenzien, Alexa Mieg, Annika Wolfsberger, Andreas Andreou, Nora Nevermann, Uwe Pelzer, Uli Fehrenbach, Lena Marie Haiden, Robert Öllinger, Wenzel Schöning, Moritz Schmelzle, Johann Pratschke. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbeck's Archives of Surgery 2021; 406(5): 1499 doi: 10.1007/s00423-021-02154-4
|
13 |
Metha Songthamwat, Nittaya Chamadol, Narong Khuntikeo, Jadsada Thinkhamrop, Supinda Koonmee, Nathaphop Chaichaya, Jeffrey Bethony, Bandit Thinkhamrop. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1246-9
|
14 |
Bei Li, Xian-Ze Xiong, Yong Zhou, Si-Jia Wu, Zhen You, Jiong Lu, Nan-Sheng Cheng. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World Journal of Gastroenterology 2017; 23(36): 6685-6693 doi: 10.3748/wjg.v23.i36.6685
|
15 |
Alexander V. Fisher, Sean M. Ronnekleiv-Kelly. Surgical Management of Hilar Cholangiocarcinoma. Current Surgery Reports 2018; 6(8) doi: 10.1007/s40137-018-0210-0
|
16 |
Hai‐Jie Hu, Yan‐Wen Jin, Anuj Shrestha, Wen‐Jie Ma, Jun‐Ke Wang, Fei Liu, Ya‐Yun Zhu, Rong‐Xing Zhou, Parbatraj Regmi, Nan‐Sheng Cheng, Fu‐Yu Li. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China. Cancer Medicine 2019; 8(4): 1567 doi: 10.1002/cam4.2052
|
17 |
Qiao Ke, Bin Wang, Nanping Lin, Lei Wang, Jingfeng Liu. Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1749-7
|
18 |
Qiao Ke, Yuqing Chen, Qizhen Huang, Nanping Lin, Lei Wang, Jingfeng Liu, Gianfranco D. Alpini. Does additional resection of a positive microscopic ductal margin benefit patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. PLOS ONE 2020; 15(5): e0232590 doi: 10.1371/journal.pone.0232590
|
19 |
Kevin Ka-Wan Chu, Kelly Hiu-Ching Wong, Kenneth Siu-Ho Chok. Expanding Indications for Liver Transplant: Tumor and Patient Factors. Gut and Liver 2021; 15(1): 19 doi: 10.5009/gnl19265
|
20 |
Yunseok Namn, Juan Carlos Bucobo. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_13-1
|
21 |
Lei Liang, Chao Li, Ming-Da Wang, Hao Xing, Yong-Kang Diao, Hang-Dong Jia, Wan Yee Lau, Timothy M. Pawlik, Cheng-Wu Zhang, Feng Shen, Dong-Sheng Huang, Tian Yang. The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis. International Journal of Clinical Oncology 2021; 26(9): 1575 doi: 10.1007/s10147-021-01967-z
|
22 |
Tian‐Run Lv, Wen‐Jie Ma, Fei Liu, Hai‐Jie Hu, Yan‐Wen Jin, Fu‐Yu Li. Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post‐hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single‐center experience in China. Cancer Medicine 2024; 13(13) doi: 10.1002/cam4.7342
|
23 |
Jun-Zhe Zhang, Chuan-Xin Yang, Si Gao, Jun-Feng Bu, Qin-Qin Li, Hao-Lu Wang, Kai-Ni Yang, Shan-Shi Tong, Li-Jun Qian, Jin Zhang, Rong Hua, Yong-Wei Sun, Jia-Yan Yan, Wei Chen. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03126-2
|
24 |
N T E Bird, A McKenna, J Dodd, G Poston, R Jones, H Malik. Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. British Journal of Surgery 2018; 105(11): 1408 doi: 10.1002/bjs.10921
|
25 |
Zhi-Peng Liu, Wei-Yue Chen, Zi-Ran Wang, Xing-Chao Liu, Hai-Ning Fan, Lei Xu, Yu Pan, Shi-Yun Zhong, Dan Xie, Jie Bai, Yan Jiang, Yan-Qi Zhang, Hai-Su Dai, Zhi-Yu Chen. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.849053
|
26 |
Richard W. D. Gilbert, Tori Lenet, Sean P. Cleary, Rory Smoot, Ching-Wei D. Tzeng, Flavio G. Rocha, Guillaume Martel, Kimberly A. Bertens. Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 2022; 29(11): 6759 doi: 10.1245/s10434-022-11990-7
|
27 |
Yudong Wang, Wenkang Fu, Zengwei Tang, Wenbo Meng, Wence Zhou, Xun Li. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma. Medicine 2018; 97(34): e12025 doi: 10.1097/MD.0000000000012025
|
28 |
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmad Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia, Ammara Naveed. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(9): 1018-1042 doi: 10.3748/wjg.v30.i9.1018
|
29 |
Hans-Michael Hau, Felix Meyer, Nora Jahn, Sebastian Rademacher, Robert Sucher, Daniel Seehofer. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. Journal of Clinical Medicine 2020; 9(10): 3152 doi: 10.3390/jcm9103152
|
30 |
Xi-Wen Ye, Hai-Jie Hu, Xian-Ze Xiong, Jiong Lu, Nan-Sheng Cheng. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma. Surgery Today 2021; 51(8): 1352 doi: 10.1007/s00595-021-02249-x
|
31 |
Anusha Kalbasi, Edgar Ben-Josef. Radiation Therapy for Gastrointestinal Cancers. 2017; : 131 doi: 10.1007/978-3-319-43115-4_11
|
32 |
Hans-Michael Hau, Mareen Devantier, Nora Jahn, Elisabeth Sucher, Sebastian Rademacher, Daniel Seehofer, Robert Sucher. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA). Cancers 2021; 13(19): 4772 doi: 10.3390/cancers13194772
|
33 |
Rong Yin, Shasha Xu, Jing Zhu, Haiou Zhu, Chao He. Risk Factors for Negative Emotions in Patients Undergoing Radical Resection of Hilar Cholangiocarcinoma and Their Influence on Prognosis. International Journal of General Medicine 2023; : 5841 doi: 10.2147/IJGM.S440469
|
34 |
Hai-Jie Hu, Yan-Wen Jin, Rong-Xing Zhou, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Fei Liu, Nan-Sheng Cheng, Fu-Yu Li. Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?. Journal of Gastrointestinal Surgery 2018; 22(7): 1204 doi: 10.1007/s11605-018-3711-3
|
35 |
Gu-wei Ji, Fei-peng Zhu, Ke Wang, Chen-yu Jiao, Zi-cheng Shao, Xiang-cheng Li. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy. Journal of Gastrointestinal Surgery 2017; 21(4): 666 doi: 10.1007/s11605-017-3377-2
|
36 |
Masayuki Akita, Tetsuo Ajiki, Taku Matsumoto, Kenta Shinozaki, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Masahiro Kido, Takumi Fukumoto, Yonson Ku. Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer. Journal of Gastrointestinal Surgery 2017; 21(6): 983 doi: 10.1007/s11605-017-3388-z
|
37 |
Hai-Jie Hu, Yan-Wen Jin, Rong-Xing Zhou, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Fei Liu, Nan-Sheng Cheng, Fu-Yu Li. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2019; 23(3): 510 doi: 10.1007/s11605-018-3892-9
|
38 |
Poowanai Sarkhampee, Sunhawit Junrungsee, Apichat Tantraworasin, Pongserath Sirichindakul, Weeris Ouransatien, Satsawat Chansitthichok, Nithi Lertsawatvicha, Paiwan Wattanarath. Survival outcomes of surgical resection in perihilar cholangiocarcinoma in endemic area of O. Viverrini, Northeast Thailand. Asian Journal of Surgery 2024; 47(7): 2991 doi: 10.1016/j.asjsur.2024.03.116
|
39 |
Tian-Run Lv, Wen-Jie Ma, Fei Liu, Hai-Jie Hu, Yan-Wen Jin, Fu-Yu Li. The significance of peri-neural invasion in patients with resected hilar cholangiocarcinoma: A single-center experience in China. Asian Journal of Surgery 2024; 47(1): 274 doi: 10.1016/j.asjsur.2023.08.110
|
40 |
T Ebata, T Mizuno, Y Yokoyama, T Igami, G Sugawara, M Nagino. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Journal of British Surgery 2018; 105(7): 829 doi: 10.1002/bjs.10556
|
41 |
Jie He, Yuanyuan Huang, Na Huang, Jiaqing Jiang. Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1363843
|
42 |
Wei Tang, Jian-Guo Qiu, Xin Deng, Shan-Shan Liu, Luo Cheng, Jia-Rui Liu, Cheng-You Du, Robert Jeenchen Chen. Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLOS ONE 2021; 16(3): e0248534 doi: 10.1371/journal.pone.0248534
|
43 |
Xing-Hua Huang, Yi Jiang, Li-Zhi Lv, Huan-Zhang Hu. Long-term tumor-free survival after liver transplantation for the treatment of hilar cholangiocarcinoma: A case report. Asian Journal of Surgery 2021; 44(8): 1081 doi: 10.1016/j.asjsur.2021.05.012
|
44 |
Emrullah Birgin, Erik Rasbach, Christoph Reissfelder, Nuh N. Rahbari. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma. European Journal of Surgical Oncology 2020; 46(5): 747 doi: 10.1016/j.ejso.2020.01.023
|
45 |
Yunseok Namn, Juan Carlos Bucobo. Hepato-Pancreato-Biliary Malignancies. 2022; : 265 doi: 10.1007/978-3-030-41683-6_13
|
46 |
Lei Liang, Chao Li, Hang-Dong Jia, Yong-Kang Diao, Hao Xing, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Dong-Sheng Huang, Cheng-Wu Zhang, Tian Yang. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Therapeutic Advances in Gastrointestinal Endoscopy 2021; 14 doi: 10.1177/2631774521993065
|
47 |
Jung Ho Im, Gi Hong Choi, Woo Jung Lee, Dai Hoon Han, Seung Woo Park, Seungmin Bang, Hye Jin Choi, Jinsil Seong. Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology 2021; 147(8): 2435 doi: 10.1007/s00432-021-03524-7
|
48 |
Bingrong Chen, Seng Wang Fu, Lungen Lu, Hang Zhao. A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1092563
|
49 |
Masayuki Akita, Tetsuo Ajiki, Kimihiko Ueno, Daisuke Tsugawa, Yu Hashimoto, Motofumi Tanaka, Masahiro Kido, Hirochika Toyama, Takumi Fukumoto. Predictors of postoperative early recurrence of extrahepatic bile duct cancer. Surgery Today 2020; 50(4): 344 doi: 10.1007/s00595-019-01880-z
|
50 |
Hai‐Jie Hu, Zhen‐Ru Wu, Yan‐Wen Jin, Wen‐Jie Ma, Qin Yang, Jun‐Ke Wang, Fei Liu, Fu‐Yu Li. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives. ANZ Journal of Surgery 2019; 89(5): 476 doi: 10.1111/ans.14765
|
51 |
Jung Min Lee, Hongbeom Kim, Hee Ju Sohn, Yoo Jin Choi, Jae Seung Kang, Youngmin Han, Wooil Kwon, Jin-Young Jang. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer. Annals of Surgical Treatment and Research 2022; 102(2): 100 doi: 10.4174/astr.2022.102.2.100
|
52 |
Nicholas T.E. Bird, Nichola Manu, Leonard Quinn, Alex Needham, Robert Jones, Stephen Fenwick, Graeme Poston, Daniel Palmer, Hassan Malik. Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma. HPB 2019; 21(10): 1376 doi: 10.1016/j.hpb.2019.02.014
|